Quince Therapeutics
QNCX
#8423
Rank
$0.21 B
Marketcap
$3.86
Share price
-1.03%
Change (1 day)
89.22%
Change (1 year)

Quince Therapeutics (QNCX) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $0.10 Billion USD

According to Quince Therapeutics's latest financial reports the company's total liabilities are $0.10 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Quince Therapeutics - Total liabilities on balance sheet (from 2018 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$84.33 M1.83%
2023-12-31$82.81 M2396.71%
2022-12-31$3.31 M-77.35%
2021-12-31$14.64 M-14.89%
2020-12-31$17.2 M93.48%
2019-12-31$8.89 M-91.57%
2018-12-31$0.10 B276.82%
2017-12-31$27.99 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
$24.27 M-76.99%๐Ÿ‡บ๐Ÿ‡ธ USA